Jiangsu Aidea Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 73.59 million compared to CNY 154.63 million a year ago. Revenue was CNY 73.78 million compared to CNY 157 million a year ago.

Net loss was CNY 68.19 million compared to net income of CNY 12.86 million a year ago. Basic loss per share from continuing operations was CNY 0.16 compared to basic earnings per share from continuing operations of CNY 0.03 a year ago. Diluted loss per share from continuing operations was CNY 0.16 compared to diluted earnings per share from continuing operations of CNY 0.03 a year ago.